Shares in Eli Lilly (NYSE:LLY) rose today after the drug manufacturer missed earnings expectations, but beat revenue estimates on Wall Street with its 4th quarter results.
The Indianapolis-based company posted profits of $771.8 million on sales of $5.76 billion for the 3 months ended Dec. 31, for bottom-line growth of 61.3% on sales growth of 7.1% compared with the same period last year.
Adjusted to exclude 1-time items, earnings per share were 95¢, behind consensus on The Street, where analysts were looking for sales of $5.55 billion.
Get the full story at our sister site, Drug Delivery Business News.
The post Eli Lilly posts mixed Q4 earnings appeared first on MassDevice.
from MassDevice http://ift.tt/2jR7Hd0
Cap comentari:
Publica un comentari a l'entrada